Literature DB >> 16356429

Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism.

Jacoba J Bongers-Schokking1, Sabine M P F de Muinck Keizer-Schrama.   

Abstract

OBJECTIVES: To evaluate the influence of initial and postinitial treatment factors on cognitive, psychomotor, and psychological outcome in schoolchildren with congenital hypothyroidism (CH). STUDY
DESIGN: We studied 45 patients (19 with severe CH and 26 with mild CH) and 37 control children by correlating initial and postinitial treatment factors (free thyroxine and thyroid-stimulating hormone [TSH] concentrations, and the percentage of overtreatment and undertreatment periods) with the results of neuropsychological tests and behavior (as reported on the Teacher Report Form [TRF]).
RESULTS: The global IQ of the children with CH was comparable to that of the controls; visuomotor and verbal scores were lower, and total TRF scores were higher. Ethnic group, previous development, and overtreatment predicted IQ and verbal scores, with higher scores seen for the overtreated patients than for the control children and those patients who had not been overtreated. As initial treatment was less satisfactory, total TRF scores were higher.
CONCLUSIONS: Our study suggests that initial and postinitial suboptimal treatment of CH leads to abnormalities in IQ and specific fields. Overtreatment may advance cognitive development in 5-1/2- to 7-year-olds. Suboptimal initial treatment may lead to behavioral problems. We recommend that TSH concentrations be maintained within the normal range in patients with CH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356429     DOI: 10.1016/j.jpeds.2005.09.031

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  Diagnosis and treatment of subclinical hypothyroidism detected by neonatal screening.

Authors:  Xiao-Xiao Chen; Yu-Feng Qin; Xue-Lian Zhou; Ru-Lai Yang; Yu-Hua Shi; Hua-Qing Mao; Yi-Ping Qu; Xu Wang; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  [38 year-old patient with suspected congenital hormonal dysfunction].

Authors:  T Bergmann; E G Hahn; P Lohse; I A Harsch
Journal:  Internist (Berl)       Date:  2010-10       Impact factor: 0.743

Review 3.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

4.  Individualized treatment to optimize eventual cognitive outcome in congenital hypothyroidism.

Authors:  Jacoba J Bongers-Schokking; Wilma C M Resing; Wilma Oostdijk; Yolanda B de Rijke; Sabine M P F de Muinck Keizer-Schrama
Journal:  Pediatr Res       Date:  2016-08-05       Impact factor: 3.756

Review 5.  Pediatric Hypothyroidism: Diagnosis and Treatment.

Authors:  Ari J Wassner
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

6.  microRNA-124-3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6.

Authors:  Wenjie Li; Dongpo Song; Yingmei Sun; Yanan Lv; Jinfeng Lv
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 7.  Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks.

Authors:  Eric I Benchimol; Catharine M Walsh; Simon C Ling
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

8.  Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data.

Authors:  Alex R Kemper; Lijing Ouyang; Scott D Grosse
Journal:  BMC Pediatr       Date:  2010-02-15       Impact factor: 2.125

Review 9.  Congenital hypothyroidism.

Authors:  Maynika V Rastogi; Stephen H LaFranchi
Journal:  Orphanet J Rare Dis       Date:  2010-06-10       Impact factor: 4.123

Review 10.  Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part II: Imaging, Treatment and Follow-up.

Authors:  S Sudhanshu; I Riaz; R Sharma; M P Desai; R Parikh; V Bhatia
Journal:  Indian J Pediatr       Date:  2018-02-17       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.